RxDoctor Payments Data

Fausta Ditah

Gastroenterology · Clarksville, TNNPI 1063675692

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 52.8% of the total. That places this record below the midpoint for gastroenterology clinicians in TN, where the typical reported total is $2,975.

$3,483in general payments, 2019–2025

Across 219 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$392
  • Johnson & Johnson$263
  • QOL Medical, LLC$137
  • Bristol Myers Squibb$127
  • Sanofi$105
  • plus $617 from 17 others
$31,639in research payments, 2019–2025

Across 9 payments — averaging $3515.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$32K

What the payments were for

  • Food & beverage$3,471100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,483 in reported general payments places this provider in the 50th percentile of 336 gastroenterology providers in Tennessee.

See all gastroenterology providers in Tennessee

Medicare billing

Part B allowed, 2024
$102,627
Medicare patients
389
Services billed
887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide23$19,580
TrulancePlecanatide13$8,131
Pantoprazole Sodium80$1,283
Dicyclomine Hcl33$607
Mycophenolate Mofetil11$485
Omeprazole19$252
Spironolactone15$217
Nortriptyline Hcl13$83
Furosemide12$52

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,841$19,58023 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$392$8,13113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 336 gastroenterology providers in Tennessee.

Other gastroenterology in Clarksville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →